CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
Authors
AI McCormack
AP Heaney
+32 more
B Ambrosi
CE Fadul
D Lubke
E Horvath
E Rivera
EU Tan
F Amatori
FineRL FD
G Assie
G Kontogeorgos
G Widhalm
GA Kaltsas
J Hoek van der
Jeffrey N. Bruce
K Kovacs
K Kovacs
KR Mullan
LR Salgado
M Andreassen
Marie S. Thearle
MH Kulke
MH Kulke
ML Raffin-Sanson
Pamela U. Freda
PJ Jenkins
PJ Pernicone
Robert L. Fine
S Lim
S Mohammed
Steven R. Isaacson
VJ Moyes
Yoomi Lee
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 03/12/2019